Verisante Technology Inc. (VRSEF)
Verisante Technology Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Vancouver, BC, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $179,487. On trailing twelve-month figures it carries a trailing P/E of 0.65, a net margin of 0.0%. Its beta of 3.94 implies it has historically moved more than the broad market.
Verisante Technology Inc. presently lacks substantial business operations. Historically, the company focused on developing and manufacturing advanced diagnostic devices for cancer. Originally founded as T-Ray Science Inc., it adopted its current name, Verisante Technology Inc., in January 2011. The firm was established in 2006 and is headquartered in Vancouver, Canada.
Verisante Technology Inc. is most often compared with the following Healthcare names: